Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-018313
Filing Date
2015-10-13
Accepted
2015-10-13 15:09:11
Documents
11
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q blud20150831_10q.htm 10-Q 1528882
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16488
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16282
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5854
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6014
  Complete submission text file 0001437749-15-018313.txt   9498091

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS blud-20150831.xml EX-101.INS 2758454
7 EXHIBIT 101.SCH blud-20150831.xsd EX-101.SCH 66628
8 EXHIBIT 101.CAL blud-20150831_cal.xml EX-101.CAL 50333
9 EXHIBIT 101.DEF blud-20150831_def.xml EX-101.DEF 340264
10 EXHIBIT 101.LAB blud-20150831_lab.xml EX-101.LAB 434846
11 EXHIBIT 101.PRE blud-20150831_pre.xml EX-101.PRE 342452
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 151155946
SIC: 2835 In Vitro & In Vivo Diagnostic Substances